Explore the latest in hepatitis B, including recent advances in diagnosis and antiviral treatment, prevention of complications, and more.
This cohort study examines the association of preoperative antiviral treatment with the incidences of microvascular invasion and posthepatectomy early tumor recurrence in adult patients with hepatitis B virus–related hepatocellular carcinoma.
This cohort study uses data from the Korean National Health Insurance Service database to compare the risk of hepatocellular cancer associated with entecavir vs tenofovir disoproxil fumarate in patients receiving long-term treatment for chronic hepatitis B infection.
This analysis of population-level data examines evidence of the association between body mass index and development of hepatocellular carcinoma among men and women with chronic hepatitis B virus infection.
This narrative review summarizes recent advances in the epidemiology, identification, natural history, diagnosis, treatment, and prognosis of chronic hepatitis B virus (HBV).
This Medical Letter review compares a newly approved 2-dose hepatitis B virus vaccine that uses a synthetic oligonucleotide immunostimulatory adjuvant, and is licensed for use in adults, with other commercially available 3-dose vaccines.
A 30-year-old woman had widespread, erythematous, purpuric macules and papules on the abdomen and extremities. A skin punch biopsy showed extravasated erythrocytes, a neutrophilic infiltrate, fibrinoid necrosis, and broken-down neutrophils releasing nuclear debris. What would you do next?
This case-matched population study examines the pattern and recurrence rate of de novo hepatocellular carcinoma in patients with liver cirrhosis.
This follow-up of a randomized clinical trial compares long-term immune responses to the standard hepatitis B virus vaccine regimen with a 4-injection intramuscular double-dose regimen and a 4-injection intradermal low-dose regimen among patients with HIV-1 infection.
This Evidence Synopsis reviews the screening recommendations for hepatitis B virus infection.
This cohort study uses data on patients who underwent liver resection for hepatitis B virus–related hepatocellular carcinoma to develop a nomogram for preoperative estimation of microvascular invasion.
This JAMA Clinical Guidelines Synopsis summarizes the US Preventive Services Task Force’s 2014 guidelines on screening for gonorrhea, chlamydia, and hepatitis B.
This Viewpoint discusses important questions about how to efficiently screen for hepatitis B virus (HBV) for those at risk of HBV reactivation.
This Editorial discusses the optimal antiviral prophylaxis against hepatitis B reactivation in patients receiving rituximab-based chemotherapy for lymphoma.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: